RecruitingPhase 2NCT05868733
A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa
Studying Lassa fever
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- International AIDS Vaccine Initiative
- Intervention
- Day 1 Lower Dose (2×106 pfu)(drug)
- Enrollment
- 612 enrolled
- Eligibility
- 70 years · All sexes
- Timeline
- 2024 – 2027
Study locations (3)
- Noguchi Memorial Institute for Medical Research (NMIMR), Accra, Ghana
- PREVAIL_ John F. Kennedy Medical Center (JFK), Monrovia, Liberia
- Walter Reed Program - Nigeria, Wuse, Nigeria
Collaborators
Coalition for Epidemic Preparedness Innovations
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05868733 on ClinicalTrials.govOther trials for Lassa fever
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07419373ARN-75039 Lassa Fever Treatment in West AfricaArisan Therapeutics, Inc.
- RECRUITINGPHASE2, PHASE3NCT06212336ISTH/ANRS 0409s INTEGRATE Lassa Fever StudyIrrua Specialist Teaching Hospital
- ACTIVE NOT RECRUITINGPHASE1NCT06546709DMID 23-0015; Lassa Fever CVD 1000Wilbur Chen, MD, MS
- RECRUITINGPHASE2NCT06222723LAssa Fever Adjunct Treatment With DEXamethasoneBernhard Nocht Institute for Tropical Medicine
- ACTIVE NOT RECRUITINGNCT03655561Lassa Fever Clinical Course and Prognostic Factors in NigeriaAlliance for International Medical Action